Women's Health Issues
Volume 20, Issue 5 , Pages 299-303 , September 2010

The Underappreciated Impact of Heart Disease

  • Emil M. deGoma, MD

      Affiliations

    • Cardiovascular Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    • Corresponding Author InformationCorrespondence to: Dr. Emil M. deGoma, 3400 Spruce Street, Penn Tower, 6th Floor Philadelphia, PA 19104.
    • ,
  • Ronald P. Karlsberg, MD

      Affiliations

    • Cardiovascular Research Foundation of Southern California, Los Angeles, California
    • ,
  • Debra R. Judelson, MD

      Affiliations

    • Cardiovascular Research Foundation of Southern California, Los Angeles, California
    • ,
  • Matthew J. Budoff, MD

      Affiliations

    • Los Angeles Biomedical Research Institute at Harbor-UCLA, Los Angeles, California

Received 22 January 2010 ,Revised 3 May 2010 ,Accepted 5 May 2010.

References 

  1. American Cancer Society. (2009). Breast cancer facts and figures 2009-2010. Atlanta, GA: American Cancer Society.
  2. American Heart Association. (2009). Heart disease and stroke statistics update 2009. Dallas, TX: American Heart Association.
  3. Arad Y, Goodman KJ, Roth M, Newstein D, Guerci AD. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: The St. Francis Heart Study. Journal of the American College of Cardiology. 2005;46:158–165
  4. Arad Y, Spadaro LA, Roth M, Newstein D, Guerci AD. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: The St. Francis Heart Study randomized clinical trial. Journal of the American College of Cardiology. 2005;46:166–172
  5. Budoff MJ, Achenbach S, Blumenthal RS, Carr JJ, Goldin JG, Greenland P, et al. Assessment of coronary artery disease by cardiac computed tomography: A scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation. 2006;114:1761–1791
  6. Centers for Disease Control and Prevention . National vital statistics reports: Deaths, final data for 2006. Bethesda: Author; 2009;
  7. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928–935
  8. Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: A review for clinicians. Journal of the American College of Cardiology. 2009;54:1209–1227
  9. Crouse JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: The METEOR trial. JAMA. 2007;297:1344–1353
  10. Espeland MA, O'Leary DH, Terry JG, Morgan T, Evans G, Mudra H. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of hMG-COA reductase inhibitors. Current Controlled Trials in Cardiovascular Medicine. 2005;6:3
  11. Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: The Multi-Ethnic Study of Atherosclerosis (MESA). Archives of Internal Medicine. 2008;168:1333–1339
  12. Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: A report of the American College of Cardiology Foundation clinical expert consensus task force (ACCF/AHA writing committee to update the 2000 expert consensus document on electron beam computed tomography). Circulation. 2007;115:402–426
  13. Greenland P, Smith SC, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: Role of traditional risk factors and noninvasive cardiovascular tests. Circulation. 2001;104:1863–1867
  14. Kaul P, Douglas PS. Atherosclerosis imaging: Prognostically useful or merely more of what we know?. Circulation. Cardiovascular Imaging. 2009;2:150–160
  15. Lakoski SG, Greenland P, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as “low risk” based on Framingham risk score: The Multi-Ethnic Study of Atherosclerosis (MESA). Archives of Internal Medicine. 2007;167:2437–2442
  16. Lloyd-Jones DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, et al. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113:791–798
  17. Mosca L, Mochari-Greenberger H, Dolor RJ, Newby LK, Robb KJ. Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health. Circulation. Cardiovascular Quality Outcomes. 2010;3:120–127
  18. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: The ARIC (Atherosclerosis Risk in Communities) study. Journal of the American College of Cardiology. 2010;55:1600–1607
  19. National Cholesterol Education Program . Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel iii). JAMA. 2001;285:2486–2497
  20. National Heart, Lung, and Blood Institute . About the heart truth. Bethesda: Author; 2009;
  21. Pasternak RC, Abrams J, Greenland P, Smaha LA, Wilson PW, Houston-Miller N. 34th Bethesda conference: Task force #1—Identification of coronary heart disease risk: Is there a detection gap?. Journal of the American College of Cardiology. 2003;41:1863–1874
  22. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, et al. Diagnostic performance of digital versus film mammography for breast-cancer screening. New England Journal of Medicine. 2005;353:1773–1783
  23. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA. 2010;303:1610–1616
  24. Redberg RF, Benjamin EJ, Bittner V, Braun LT, Goff DC, Havas S, et al. ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: A report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: Endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research. Journal of the American College of Cardiology. 2009;54:1364–1405
  25. Ridker PM, MacFadyen JG, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin (JUPITER). Circulation. Cardiovascular Quality Outcomes. 2009;2:616–623
  26. Rumberger JA. Coronary artery calcium scanning using computed tomography: Clinical recommendations for cardiac risk assessment and treatment. Seminars in Ultrasound, CT, and MR. 2008;29:223–229
  27. National Cancer Institute . Surveillance epidemiology and end results. Bethesda: Author; 2009;
  28. Shaw LJ, Bugiardini R, Merz CN. Women and ischemic heart disease: Evolving knowledge. Journal of the American College of Cardiology. 2009;54:1561–1575
  29. Smith SC, Greenland P, Grundy SM. AHA conference proceedings. Prevention Conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: Executive summary. American Heart Association. Circulation. 2000;101:111–116
  30. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention of coronary heart disease in women through diet and lifestyle. New England Journal of Medicine. 2000;343:16–22
  31. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the American Society of Echocardiography carotid intima-media thickness task force. Endorsed by the Society for Vascular Medicine. Journal of the American Society of Echocardiography. 2008;21:93–111quiz 189–190
  32. Trivedi AN, Rakowski W, Ayanian JZ. Effect of cost sharing on screening mammography in Medicare health plans. New England Journal of Medicine. 2008;358:375–383
  33. U.S. Preventive Services Task Force . Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine. 2009;151:716–726

 Dr. deGoma's salary is partially funded via NIH National Heart Lung and Blood Institute grant K12 HL083772-01.

PII: S1049-3867(10)00058-7

doi: 10.1016/j.whi.2010.05.001

Women's Health Issues
Volume 20, Issue 5 , Pages 299-303 , September 2010

Article Tools